-
1
-
-
0029767419
-
Analysis of the in vitro activity of trovafloxacin (CP-99,219) against Bacteroides species
-
(Suppl. 3)
-
Snydman D.R., McDermott L. Analysis of the in vitro activity of trovafloxacin (CP-99,219) against Bacteroides species. Infect Dis Clin Pract. 5:1996;96-100. (Suppl. 3).
-
(1996)
Infect Dis Clin Pract
, vol.5
, pp. 96-100
-
-
Snydman, D.R.1
McDermott, L.2
-
2
-
-
0028096987
-
In vitro activity of the new fluoroquinolone CP-99,219
-
Neu H.C., Chin N. In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob Agents Chemother. 38:1984;2615-2622.
-
(1984)
Antimicrob Agents Chemother
, vol.38
, pp. 2615-2622
-
-
Neu, H.C.1
Chin, N.2
-
3
-
-
0027999053
-
Activity of CP-99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin-tazobactam against 489 anaerobes
-
Spangler S.K., Jacobs M.R., Appelbaum P.C. Activity of CP-99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother. 38:1994;2471-2476.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 2471-2476
-
-
Spangler, S.K.1
Jacobs, M.R.2
Appelbaum, P.C.3
-
4
-
-
0029768777
-
Efficacy of trovafloxacin (CP-99,219), a new fluoroquinolone, in an animal model of intraabdominal sepsis
-
(Suppl. 3)
-
Onderdonk A.B. Efficacy of trovafloxacin (CP-99,219), a new fluoroquinolone, in an animal model of intraabdominal sepsis. Infect Dis Clin Pract. 5:1996;S117-S119. (Suppl. 3).
-
(1996)
Infect Dis Clin Pract
, vol.5
-
-
Onderdonk, A.B.1
-
5
-
-
0031019078
-
In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteriodes fragilis and Escherichia coli
-
Thadepalli H.U., Reddy S.K., Chuah F., Thadepalli C., Malilay R.J., Polzer R. et al. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteriodes fragilis and Escherichia coli. Antimicrob Agents Chemother. 41:1997;583-586.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 583-586
-
-
Thadepalli, H.U.1
Reddy, S.K.2
Chuah, F.3
Thadepalli, C.4
Malilay, R.J.5
Polzer, R.6
-
6
-
-
0029805020
-
Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: In vitro pharmacodynamic simulation
-
Balcabao I.P., Aguilar L., Martín M., García Y., Dal-Ré R., Prieto J. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: In vitro pharmacodynamic simulation. Antimicrob Agents Chemother. 40:1996;2904-2906.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 2904-2906
-
-
Balcabao, I.P.1
Aguilar, L.2
Martín, M.3
García, Y.4
Dal-Ré, R.5
Prieto, J.6
-
7
-
-
0031049862
-
In-vitro pharmacodynamic simulation of clavulanic acid concentrations on Staphylococcus aureus and Haemophilus influenzae β-lactamase activity
-
Martín M., Aguilar L., Balcabao I.P., Gómez-Lus M.L., Dal-Ré R., Prieto J. In-vitro pharmacodynamic simulation of clavulanic acid concentrations on Staphylococcus aureus and Haemophilus influenzae β-lactamase activity. J Antimicrob Chemother. 39:1997;290-292.
-
(1997)
J Antimicrob Chemother
, vol.39
, pp. 290-292
-
-
Martín, M.1
Aguilar, L.2
Balcabao, I.P.3
Gómez-Lus, M.L.4
Dal-Ré, R.5
Prieto, J.6
-
8
-
-
0003772229
-
-
National Committee for Clinical Laboratory Standards. Approved standard. NCCLS document M7-A3. National Committee for Clinical Laboratory Standards, Villanova, PA
-
National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility test for bacterial that grow aerobically. 3rd ed. Approved standard. NCCLS document M7-A3. National Committee for Clinical Laboratory Standards, Villanova, PA, 1993.
-
(1993)
Methods for Antimicrobial Susceptibility Test for Bacterial That Grow Aerobically. 3rd Ed.
-
-
-
9
-
-
0003634054
-
-
National Committee for Clinical Laboratory Standards. Approved standard. NCCLS document M11-A3. National Committee for Clinical Laboratory Standards, Villanova, PA
-
National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 3rd ed. Approved standard. NCCLS document M11-A3. National Committee for Clinical Laboratory Standards, Villanova, PA, 1993.
-
(1993)
Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. 3rd Ed.
-
-
-
10
-
-
38249019977
-
Assessing cidal activity of antimicrobial agents: Problems and pitfalls
-
Amsterdam D. Assessing cidal activity of antimicrobial agents: problems and pitfalls. Antimicrob Newsl. 7:1990;49-56.
-
(1990)
Antimicrob Newsl
, vol.7
, pp. 49-56
-
-
Amsterdam, D.1
-
11
-
-
38249014513
-
The MIC: Myth and reality
-
Amsterdam D. The MIC: myth and reality. Antimicrob Newsl. 8:1992;9-16.
-
(1992)
Antimicrob Newsl
, vol.8
, pp. 9-16
-
-
Amsterdam, D.1
-
12
-
-
0029763343
-
Activity of the antibiotic CP-99,219 (trovafloxacin) in a mixed microflora growth system model of intraabdominal infections in humans
-
(Suppl. 3)
-
Ross R.A., Onderdonk A. Activity of the antibiotic CP-99,219 (trovafloxacin) in a mixed microflora growth system model of intraabdominal infections in humans. Infect Dis Clin Pract. 5:1996;S110-S112. (Suppl. 3).
-
(1996)
Infect Dis Clin Pract
, vol.5
-
-
Ross, R.A.1
Onderdonk, A.2
-
13
-
-
0028891586
-
Effect of aerobic and anaerobic environment on antistaphylococcal activities of five fluoroquinolones
-
Zabinski R.A., Walker K.J., Larson J.A., Moody G., Kaatz W., Rotschafer J.C. Effect of aerobic and anaerobic environment on antistaphylococcal activities of five fluoroquinolones. Antimicrob Agents Chemother. 39:1995;507-512.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 507-512
-
-
Zabinski, R.A.1
Walker, K.J.2
Larson, J.A.3
Moody, G.4
Kaatz, W.5
Rotschafer, J.C.6
-
14
-
-
0031983331
-
Activity of trovafloxacin (with or without ampicillin-sulbactam) against Enterococci in an in vitro dynamic model of infection
-
Zinner S., Gilbert D., Dudley N. Activity of trovafloxacin (with or without ampicillin-sulbactam) against Enterococci in an in vitro dynamic model of infection. Antimicrob Agents Chemother. 42:1998;72-77.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 72-77
-
-
Zinner, S.1
Gilbert, D.2
Dudley, N.3
-
17
-
-
0025744732
-
Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions
-
Cooper M.A., Andrews J.M., Wise R. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions. J Antimicrob Chemother. 28:1991;399-405.
-
(1991)
J Antimicrob Chemother
, vol.28
, pp. 399-405
-
-
Cooper, M.A.1
Andrews, J.M.2
Wise, R.3
-
18
-
-
0029784338
-
Bactericidal activity of trovafloxacin under anaerobic and aerobic conditions
-
(Suppl. 3)
-
Boswel F.J., Andrews J.M., Wise R. Bactericidal activity of trovafloxacin under anaerobic and aerobic conditions. Infect Dis Clin Pract. 5:1996;S113-S116. (Suppl. 3).
-
(1996)
Infect Dis Clin Pract
, vol.5
-
-
Boswel, F.J.1
Andrews, J.M.2
Wise, R.3
-
19
-
-
0024379695
-
Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against E. faecalis
-
Eliopoulos G.M., Reiszner E., . Willey S., Novick W.J., Moeleering R.C. Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against E. faecalis. Diag Microbiol Infect Dis. 12:1989;149-156.
-
(1989)
Diag Microbiol Infect Dis
, vol.12
, pp. 149-156
-
-
Eliopoulos, G.M.1
Reiszner, E.2
Willey, S.3
Novick, W.J.4
Moeleering, R.C.5
-
20
-
-
0344901426
-
Comparisons of intravenous alatrofloxacin-to-oral trovafloxacin versus intravenous imipenem/cilastatin-to-oral amoxicillin/clavulanic acid for the treatment of complicated intra-abdominal infections
-
The intra-abdominal Infections Study Group. Poster M258. 10-13 May
-
Luke DR, The intra-abdominal Infections Study Group. Comparisons of intravenous alatrofloxacin-to-oral trovafloxacin versus intravenous imipenem/cilastatin-to-oral amoxicillin/clavulanic acid for the treatment of complicated intra-abdominal infections. Poster M258. 2nd European Congress of Chemotherapy and 7th Biennial Conference of Antiinfective Agents and Chemotherapy Hamburg, 10-13 May, 1998.
-
(1998)
2nd European Congress of Chemotherapy and 7th Biennial Conference of Antiinfective Agents and Chemotherapy Hamburg
-
-
Luke, D.R.1
|